scholarly article | Q13442814 |
P50 | author | Jaroslav Rosenberger | Q45746974 |
Jitse P van Dijk | Q50634549 | ||
P2093 | author name string | Johan W Groothoff | |
Matej Skorvanek | |||
Zuzana Gdovinova | |||
Iveta Nagyova | |||
Radka Ghorbani Saeedian | |||
Martina Krokavcova | |||
P2860 | cites work | Chronic fatigue syndrome--a clinically empirical approach to its definition and study | Q24536313 |
“Mini-mental state” | Q25938989 | ||
The hospital anxiety and depression scale | Q27860968 | ||
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
Parkinsonism: onset, progression, and mortality | Q28259134 | ||
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
Fatigue in levodopa-naive subjects with Parkinson disease | Q30434565 | ||
Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study | Q30540639 | ||
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients | Q34413083 | ||
Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? | Q34556713 | ||
Depression rating scales in Parkinson's disease: critique and recommendations | Q34578187 | ||
Fatigue in Parkinson's disease: a review | Q36667874 | ||
Anxiety rating scales in Parkinson's disease: critique and recommendations | Q37269003 | ||
Fatigue in older adults: an early indicator of the aging process? | Q37741724 | ||
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease | Q37749714 | ||
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations | Q37798777 | ||
Systematic review of levodopa dose equivalency reporting in Parkinson's disease. | Q37808677 | ||
Fatigue in Parkinson's disease | Q37884077 | ||
Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology | Q39891478 | ||
The Parkinson fatigue scale. | Q40458495 | ||
Pergolide mesilate may improve fatigue in patients with Parkinson's disease | Q40993494 | ||
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. | Q42872557 | ||
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment | Q43057272 | ||
An exploratory study of activity in veterans with Parkinson's disease | Q45171892 | ||
Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease | Q48006994 | ||
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease | Q48264764 | ||
Towards an understanding of fatigue in Parkinson disease | Q48298647 | ||
Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease | Q48336115 | ||
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease | Q48398056 | ||
Non-recognition of depression and other non-motor symptoms in Parkinson's disease | Q48660726 | ||
Exacerbated physical fatigue and mental fatigue in Parkinson's disease | Q48681750 | ||
Fatigue in early Parkinson's disease. Minor inconvenience or major distress? | Q48729304 | ||
Fatigue in patients with Parkinson's disease | Q48769057 | ||
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease | Q48878240 | ||
Impact of fatigue on quality of life in patients with Parkinson's disease. | Q51893037 | ||
Is fatigue an independent and persistent symptom in patients with Parkinson disease? | Q51935419 | ||
The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue | Q52017423 | ||
Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. | Q53175429 | ||
Fatigue in Parkinson's disease | Q70514581 | ||
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial | Q80733175 | ||
Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS) | Q83318643 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1554-1561 | |
P577 | publication date | 2013-01-09 | |
P1433 | published in | Journal of Neurology | Q6295649 |
P1476 | title | Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease | |
P478 | volume | 260 |
Q64864842 | Q64864842 |
Q55073609 | Acupuncture in the treatment of fatigue in Parkinson's disease: A pilot, randomized, controlled, study. |
Q62719741 | Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease |
Q38124676 | Fatigue in healthy and diseased individuals |
Q36559298 | Risk Factors of Fatigue in Idiopathic Parkinson's Disease in a Polish Population |
Q92584079 | The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management |
Q47721519 | The associations between fatigue, apathy, and depression in Parkinson's disease |
Search more.